Şaylan, Demet

Profile URL
https://hdl.handle.net/20.500.12573/2852
Name Variants
Demet Şaylan Saylan, Demet
Job Title
Öğr. Gör.
Email Address
demet.saylan@agu.edu.tr
Main Affiliation
04.02. Moleküler Biyoloji ve Genetik
Status
Current Staff
Website
ORCID ID
0000-0002-1969-428X
Scopus Author ID
58532316200
Turkish CoHE Profile ID
7591BCB10E344740
Google Scholar ID
WtLB9q8AAAAJ
WoS Researcher ID
No research topics data found.

Sustainable Development Goals

NO POVERTY1
NO POVERTY
0
Research Products
ZERO HUNGER2
ZERO HUNGER
0
Research Products
GOOD HEALTH AND WELL-BEING3
GOOD HEALTH AND WELL-BEING
3
Research Products
QUALITY EDUCATION4
QUALITY EDUCATION
0
Research Products
GENDER EQUALITY5
GENDER EQUALITY
0
Research Products
CLEAN WATER AND SANITATION6
CLEAN WATER AND SANITATION
0
Research Products
AFFORDABLE AND CLEAN ENERGY7
AFFORDABLE AND CLEAN ENERGY
0
Research Products
DECENT WORK AND ECONOMIC GROWTH8
DECENT WORK AND ECONOMIC GROWTH
0
Research Products
INDUSTRY, INNOVATION AND INFRASTRUCTURE9
INDUSTRY, INNOVATION AND INFRASTRUCTURE
0
Research Products
REDUCED INEQUALITIES10
REDUCED INEQUALITIES
0
Research Products
SUSTAINABLE CITIES AND COMMUNITIES11
SUSTAINABLE CITIES AND COMMUNITIES
1
Research Products
RESPONSIBLE CONSUMPTION AND PRODUCTION12
RESPONSIBLE CONSUMPTION AND PRODUCTION
1
Research Products
CLIMATE ACTION13
CLIMATE ACTION
0
Research Products
LIFE BELOW WATER14
LIFE BELOW WATER
1
Research Products
LIFE ON LAND15
LIFE ON LAND
0
Research Products
PEACE, JUSTICE AND STRONG INSTITUTIONS16
PEACE, JUSTICE AND STRONG INSTITUTIONS
0
Research Products
PARTNERSHIPS FOR THE GOALS17
PARTNERSHIPS FOR THE GOALS
0
Research Products
Documents

3

Citations

2

h-index

1

Go to Scopus profile
This researcher does not have a WoS ID.
No records found in other affiliations.
Scholarly Output

3

Articles

0

Views / Downloads

1/0

Supervised MSc Theses

0

Supervised PhD Theses

0

WoS Citation Count

0

Scopus Citation Count

2

Patents

0

Projects

1

WoS Citations per Publication

0.00

Scopus Citations per Publication

0.67

Open Access Source

0

Supervised Theses

0

JournalCount
Cutting-Edge Applications of Nanomaterials in Biomedical Sciences1
Multidisciplinary Applications of Natural Science for Drug Discovery and Integrative Medicine1
Sustainable Pharmaceutical Product Development and Optimization Processes: From Eco-Design to Supply Chain Integrity1
Current Page: 1 / 1

Scopus Quartile Distribution

Quartile distribution chart data is not available

Competency Cloud

GCRIS Competency Cloud
Author of Publication: search.filters.isAuthorOfPublication.76571c05-3a36-4854-a89a-a611044c9036

Scholarly Output Search Results

Now showing 1 - 3 of 3
  • Book Part
    Isothiocyanates as Drug Candidates in Cancer Prevention and Treatment
    (IGI Global, 2023-06-16) Saylan, Demet; Cebeci, Fatma
    Cancer is the second most common cause of death worldwide. Many methods such as surgery, chemotherapy, radiation therapy, etc. are being used for treatment. Most patients have a combination treatment with chemotherapy along with surgery or radiotherapy or both. Chemotherapy kills cancer cells by preventing them from reproducing, growing, and spreading in the body. Recently, safer alternatives to chemotherapy have been discovered and developed, as most of the drugs used in cancer treatment have side effects and a serious impact on patient comfort. As an alternative, the phytochemicals found in daily consumed plants are attractive candidates for clinical/pre-clinical evaluation because of their higher safety. In this context, certain degradation products of glucosinolates (isothiocyanates) are promising agents for cancer prevention and treatment. © 2023 Elsevier B.V., All rights reserved.
  • Book Part
    Sustainable Strategies for Cancer Phytomedicine: Balancing Efficacy and the Environment Responsibility
    (Springer Nature, 2025) Sari, Sibel; Saylan, Demet
    Cancer is a complex disease, with approximately six million new cases reported annually. Despite the numerous treatment strategies employed worldwide, the severity of cancer continues to increase. Conventional cancer treatments, such as surgery, radiotherapy, and chemotherapy, are standard practices, but their clinical success is constrained by toxic side effects leading to damage to healthy tissues, unavoidable off-target effects, and significant cancer recurrence resulting from incomplete surgical removal. Therefore, interest in alternative therapies sourced primarily from natural products is increasing. The popularity of phytomedicine in cancer treatment approaches is increasing because of its efficacy, affordability, accessibility, and minimal adverse effects. Additionally, green chemistry approaches can be used to synthesize a wide array of anticancer drugs with various chemical structures, enhancing their therapeutic efficacy while minimizing or eliminating side effects and toxicity. The enhanced efficacy of cancer medicines made from plants is achieved via molecular innovations that support precise targeting. Various drug delivery systems that aim to reduce environmental pollution while reducing waste can be optimized for better results in therapy through nanotechnology. The delivery of effective cancer therapies while preserving the environment for generations to come is the objective of this approach, which includes green chemistry, sustainable production, and molecular developments. © 2025 Elsevier B.V., All rights reserved.
  • Book Part
    Citation - Scopus: 2
    Metal Nanoparticles Via Green Synthesis: A New Cancer Treatment Approach
    (IGI Global, 2023-11-03) Saylan, Demet; Erdem, İlker
    Cancer is one of the most abundant lethal diseases globally threatening public health. There is considerable research effort on the prevention, diagnosis, and treatment of cancer. The current practices for cancer treatment are usage of synthetic chemicals (i.e. chemotherapy), radiotherapy, and surgery. Besides these conventional therapies, there are contemporary, innovative approaches, e.g., targeting of the drugs to the cancerous tissues, synergetic enhancement via simultaneous usage of conventional methods, and contemporary methods. Therefore, the process of drug research and development in the field of cancer is increasingly challenging, due to the limited success of current therapies and the constant need to find safer and more effective novel approaches. The utilization of nanotechnology may present new opportunities in cancer treatment. Metal nanoparticles prepared via "bottom-up" approach may be used for triggering the selective cell apoptosis mechanisms for cancerous cells, while sparing healthy cells considerably. © 2024 Elsevier B.V., All rights reserved.